Medication recall in Canada: 5 checks before you act

On August 15, 2026, Health Canada issued a national Type I recall notice for two lots of Teva-Pregabalin 150 mg capsules because of possible contamination with another drug. The alert does not automatically apply to every package or lot. That detail matters: confirming the exact product before taking action can prevent an unnecessary interruption or a poorly understood replacement.

A recall may affect only specific strengths, formats or lots. Match the official notice to your label, call the pharmacy first and do not change treatment without situation-specific guidance. (Read more)

1. Read the official notice, not just a shared headline

Use the Government of Canada recalls database and compare the exact product name, strength, Drug Identification Number, lot number and expiry date. A social post, product photo or general drug name does not establish that your supply is affected. Recall notices can also be updated, so check the official page again when you are ready to act.

2. Ask the dispensing pharmacy to verify the lot

If the lot number is hard to read, missing from the package you still have or different from the notice, contact the pharmacy that dispensed it. The pharmacy can review its records, confirm whether the recall reaches your supply and explain the return or replacement process. Keep the product and label available until the pharmacy gives instructions; do not share it or place it in household waste.

3. Follow the instructions for this specific recall

A recall is not a universal direction to change every treatment in the same category. In the August 15 notice, Health Canada tells anyone who is unsure to check with the pharmacy and says that, apart from a severe allergic reaction, treatment should not be changed before speaking with a pharmacist or healthcare professional. Another recall may carry different directions. The current official notice is the source to follow.

4. Separate product replacement from a new prescription

A pharmacy may sometimes provide the same medication from an unaffected lot or assess another option within its professional authority. What is possible depends on the product, prescription, province, inventory and the pharmacist’s assessment. Ask whether the pharmacy can resolve the recall directly or whether a fresh prescriber decision is needed. Those are different pathways.

5. Know when the situation is urgent

The current notice says a severe allergic reaction may include trouble breathing, swelling of the face or throat, fainting or widespread hives. Call 911 for those signs or another immediate danger. For a possible side effect without immediate danger, contact a pharmacist or healthcare professional promptly. Ontario Health811 can help with non-urgent questions.

When a MedVibe request may fit

Start with the pharmacy because it can check the lot, arrange the return and confirm inventory. If the pharmacy says that a new prescription is needed to continue an established treatment, MedVibe’s prescription-renewal service can receive a request for review. A clinician examines the existing prescription, history and safety factors, then decides whether remote renewal is appropriate. Some situations need additional records, in-person assessment or another care route instead.

This guide provides general information and does not confirm that a particular product is recalled, that replacement stock is available or that a prescription can be renewed. Verify the official notice and lot with the pharmacy. For a non-urgent question in Ontario, call 811. For trouble breathing, swelling of the face or throat, loss of consciousness, immediate danger or another emergency, call 911.